NEW YORK (360Dx) – Prognos, a company applying artificial intelligence to clinical lab diagnostics, announced it has completed a $20.5 million Series C round of financing, bringing the company's total funding to $42 million.

Investors in the recent financing round include Cigna; GIS Strategic Ventures, which is the venture capital arm of the Guardian Life Insurance Company; Hermed; Hikma Ventures; Maywic; Merck Global Health Innovation Fund; and Safeguard Scientifics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
14

This webinar will discuss an effort underway at the University of North Carolina Medical Center's to overcome limitations in the hematological genomic testing workflow with artificial intelligence (AI) from Sophia Genetics.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.